BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 22690734)

  • 1. Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes.
    Sand K; Theorell J; Bruserud Ø; Bryceson YT; Kittang AO
    Cancer Immunol Immunother; 2016 Sep; 65(9):1135-47. PubMed ID: 27481108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
    Sloand EM; Mainwaring L; Fuhrer M; Ramkissoon S; Risitano AM; Keyvanafar K; Lu J; Basu A; Barrett AJ; Young NS
    Blood; 2005 Aug; 106(3):841-51. PubMed ID: 15827127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy.
    Sloand EM; Melenhorst JJ; Tucker ZC; Pfannes L; Brenchley JM; Yong A; Visconte V; Wu C; Gostick E; Scheinberg P; Olnes MJ; Douek DC; Price DA; Barrett AJ; Young NS
    Blood; 2011 Mar; 117(9):2691-9. PubMed ID: 21097671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric carcinoma subsequent to myelodysplastic syndrome with t (1; 19) chromosome translocation: A rare case report and its potential mechanisms.
    Yu W; Chen G; Sun Y; Gao S; Li W; Cui J; Sun J
    Medicine (Baltimore); 2018 Jul; 97(30):e11535. PubMed ID: 30045276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
    Cukrová V; Neuwirtová R; Dolezalová L; Belicková M; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
    Exp Hematol; 2009 Mar; 37(3):386-94. PubMed ID: 19136196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY; Li X; Chang CK; Ying SX; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Auto- and alloreactivity of T lymphocytes in myelodysplastic syndrome].
    Cukrová V; Neuwirtová R; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
    Cas Lek Cesk; 2006; 145(8):647-52; discussion 653. PubMed ID: 16995421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.